Clinical trial
Randomized Controlled Trial of Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia
NCT06518603 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial of Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 17, 2026
- Completion date
- June 30, 2027
- Enrollment
- 340 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
apnea of prematurity, development, infant, premature infant disease